Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
Phase 4 Study of Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing the Progression of Renal Failure in Atherosclerotic Renovascular Disease
Sponsor: Azienda Unita Sanitaria Locale di Piacenza
A PHASE4 clinical study on Atherosclerosis and Chronic Kidney Disease, this trial is ongoing. The trial is conducted by Azienda Unita Sanitaria Locale di Piacenza and has accumulated 5 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Change History
5 versions recorded-
Dec 2024 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Dec 2024 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jan 2021 [monthly]
Unknown Status PHASE4
First recorded
Oct 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Unita Sanitaria Locale di Piacenza
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Piacenza, Italy